Patented Laser-Drilling Technology for Two-Chamber Osmotic Tablets: Problems Solved, Advantages Secured
The practical issues in drilling two-chamber osmotic tablets are well known: wrong-side holes, inconsistent diameters, and weak inline verification. This article explains the core problems and how Academician Hou Huimin's patent CN2642449Y solves them with a closed-loop, production-ready architecture—the foundation of HUANGHAI’s Olando K3-2 solution.
The Problems You Actually Face
- Wrong-side drilling: The release orifice must be on the drug-layer side. Any mix-up ruins the release profile.
- Inconsistent hole presence/size: Missing or undersized holes shift dissolution and make lot-to-lot control difficult.
- Human-dependent checks: Manual inspection is error-prone and can’t keep up with continuous flow.
- Fragmented handling: Flipping, rechecking, and sorting are often split across devices, increasing misfeeds and rejects.
How CN2642449Y Solves These Problems
CN2642449Y (Academician Hou Huimin's patent) discloses an integrated, fully automatic system that links feeding, face detection, optional flipping, CO2 laser drilling, camera inspection, and good/reject sorting under a single controller.
- Ensures correct side: Dual face checks identify tablet orientation; a flip unit corrects it before drilling.
- Locks position before firing: Rotary nests index tablets and hold position during laser drilling.
- Verifies immediately: Post-drill camera inspection confirms hole presence/quality inline.
- Closes the loop: Non-conforming or still-wrong-side tablets are routed to a reject chute automatically.
Patent page: CN2642449Y (Academician Hou Huimin's patent) — Fully Automatic Laser Drilling Device for Two-Chamber Osmotic Tablets
System at a Glance
- Feeder drops tablets into dedicated nests on a rotary disk.
- Face check #1: Color/optical selector identifies the drug-layer side.
- If wrong: pass through the flip unit to correct orientation.
- Face check #2: Verify orientation again; if still wrong → reject path.
- Laser station: Controller indexes and pauses; CO2 laser drills the micro-hole.
- Vision QC: Camera validates that a correct hole is present.
- Sorting: Good tablets proceed; defects are diverted automatically.
Advantages You Can Defend
- Assured single-side drilling: Eliminates the root cause of release failures.
- Inline, objective verification: Camera QC detects missing/undersized holes in real time.
- Patent foundation: The architecture and workflow build on the foundational laser-drilling patent CN2642449Y of Academician Hou Huimin.
Why HUANGHAI
- Foundation: We build on the foundational laser-drilling patent CN2642449Y of Academician Hou Huimin for the key mechanisms and workflows.
Explore our current-generation system here: Olando K3-2 Pharmaceutical Laser Drilling System
Related product
Olando K3-2 Laser Drilling System
Laser drilling for bilayer osmotic tablets (6–20 mm), 0.9 mm holes with ±0.1 mm accuracy, up to 120,000 tablets per hour.
Further Reading
Frequently Asked Questions
Q: How does laser drilling create controlled-release tablets?
A: Laser drilling creates a precise aperture in the tablet coating, forming the drug delivery orifice for osmotic pump tablet systems (OROS technology). The osmotic pressure differential between the tablet core and gastrointestinal fluids drives API release through this aperture at a controlled rate. Hole diameter, depth (blind vs. through-hole), and position are critical parameters. The Olando K3-2 offers ±0.1 mm accuracy and up to 120,000 tablets/hour (based on a 15 mm tablet), with closed-loop vision inspection.
Q: Can the Olando K3-2 drill blind holes and through-holes?
A: Yes — the Olando K3-2 offers 0.9 mm blind/through-hole precision with ±0.05 mm hole depth consistency.
Q: What tablet shapes and sizes can the Olando K3-2 process?
A: The Olando K3-2 handles round bilayer tablets. Supported tablet diameters range from 6mm to 20mm. The system processes up to 120,000 tablets/hour (based on a 15 mm tablet).
Q: Is the laser drilling system designed to support FDA 21 CFR Part 11 requirements?
A: The Olando K3-2 Laser Drilling System is designed for cGMP environments, uses a Siemens PLC, and is designed to support 21 CFR Part 11 compliance (audit trail, electronic records, access control). This is designed to support FDA 21 CFR Part 11 requirements. For a full Part 11 workflow (final compliance is established by the end user's own validation), the K3-2 solution offers batch management with an MES/ERP interface. Reference customers include Shanghai Modern Pharmaceutical (12 installed units for Nifedipine CR) and Shanghai Xinyi Pharmaceutical (3 units for Doxazosin Mesylate).
Q: What are the ongoing maintenance requirements for laser drilling equipment?
A: The Olando K3-2 solution includes validation documentation templates and operator training; on-site validation is carried out by the end user. Build preventive maintenance into your equipment qualification protocol (IQ/OQ/PQ), and confirm the maintenance plan for your line with Huanghai.
Equipment Certifications & Regulatory Compliance
Huanghai manufactures under an ISO 9001:2015 quality management system. ODF production line equipment is designed to support 21 CFR Part 11 requirements.